KOMPAS.com- Indonesian State Enterprises Minister Erick Thohir has set the long-term target of exporting Covid-19 vaccines manufactured by state-run pharmaceutical company Bio Farma once it manages to fill domestic needs for the product.
“I am certain that Indonesia can meet its needs for a Covid-19 vaccine. I am just as sure that we can export [the vaccine] to other countries who might need it,” Erick said of the vaccine, which Bio Farma claimed has reached stage 3 in its development.
“The 250 million vaccine doses that Bio Farma is set to produce by next year is sufficient for Indonesia. So we will not rule out exporting [the vaccine] to other countries.”
Erick urged the public to have confidence in the vaccine once it passes stage 3 clinical tests. “Bio Farma has had experience in producing vaccines since 1980,” he said.
“Many countries, especially those in the Middle East, have either learned from Bio Farma or used the vaccines they produced. The company currently has 15 vaccines that passed the World Health Organization's Pre-Qualification tests.”
Bio Farma President Director Honesti Basyir confirmed the company’s plan to produce 250 million Covid-19 vaccines.
“We will collaborate with China-based Sinovac Biotech Ltd. Co. in producing inactivated platform vaccines, a method mastered by Bio Farma.”
Bio Farma has been recently stepping up its efforts to find a vaccine. The company's initiatives include finding 1,620 volunteers aged 18 to 59 to test its coronavirus vaccines.